According to the market intelligence report conducted by Excelsior Research the Global Influenza Vaccine Market is expected to grow by a CAGR of 12% during the forecast period 2018-2025.
Beverly Hills,, CA -- (ReleaseWire) -- 07/31/2018 --Influenza is a viral infection which is a cause of 500,000 deaths and up to 5 million cases of severe illness annually. Influenza epidemics occur annually and have a significant impact on the health as well as on the economy. Vaccination is a best way to combat Influenza as it is cost effective and have shown successful results. Aging population (more susceptibility to influenza), improving healthcare systems, growing flu awareness are some of the factors fueling demand for influenza vaccine. In 2017 majority of the Influenza Vaccine Market was dominated by U.S and EU.
Major Key players in the market identified by Excelsior Research include Sanofi Pasteur Inc, Seqirus, GlaxoSmithKline and AstraZeneca.
The report segments the Influenza Vaccine Market as follow:
By Product:
- Fluzone/Vaxigrip
- Afluria/Flurivin/Flaud/Flucelvax/Aggripal
- Fluarix/FluLaval
By Type:
- Quadrivalent Influenza Vaccines
- Trivalent Influenza Vaccines
By Region:
- U.S.
- Germany
- UK
- France
- Italy
- Spain
- Japan
- China
- India
- Brazil
- Russia
The information presented in this review is based on a Excelsior Research report, titled, "Global Influenza Vaccine Market(ByProduct-Fluzone/Vaxigrip,Afluria/Flurivin/Flaud/Flucelvax/Aggripal, Fluarix/FluLaval, By Type-Quadrivalent Influenza Vaccines, Trivalent Influenza Vaccines), Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018 – 2025"